Clinical trial
A Multicentre, Phase-II, Randomised, Double Blind, Placebo-controlled Study to Assess the Safety and the Efficacy of a Weekly Administered Dose of 30,000 IU Vitamin D (Colecalciferol) in Deficient Patients Diagnosed With PCOS
NCT04840238 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, Phase-II, Randomised, Double Blind, Placebo-controlled Study to Assess the Safety and the Efficacy of a Weekly Administered Dose of 30,000 IU Vitamin D (Colecalciferol) in Deficient Patients Diagnosed With PCOS
- Lead sponsor
- Semmelweis University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 8, 2016
- Completion date
- December 31, 2022
- Enrollment
- 115 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.